monatepil has been researched along with Heart Disease, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoki, K; Karasawa, T; Kikuta, C; Yamamoto, T | 1 |
| Hosoki, K; Karasawa, T; Nakatsuji, K; Yamamoto, T | 1 |
2 other study(ies) available for monatepil and Heart Disease, Ischemic
| Article | Year |
|---|---|
Preventive effect of monatepil on thromboxane A2 agonist-induced myocardial ischemia in rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Pressure; Calcium Channel Blockers; Dibenzothiepins; Diltiazem; Electrocardiography; Heart Rate; Male; Myocardial Ischemia; Myocardium; Oxygen Consumption; Piperazines; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Preventive effect of a new calcium antagonist, monatepil, on drug-induced ischaemic electrocardiographic changes in rats.
Topics: Administration, Oral; Animals; Blood Pressure; Calcium Channel Blockers; Coronary Vasospasm; Dibenzothiepins; Electrocardiography; Heart Rate; Injections, Intravenous; Male; Methacholine Chloride; Myocardial Ischemia; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Rats, Wistar; Vasopressins | 1993 |